Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissue Repair Cell Therapy for Osteonecrosis of the Femur Head
2006-001286-42Phase 3Active
- Sponsor
- Vericel
- Start
- May 2006
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of Tissue Repair Cells in osteonecrosis of the hip (2 arms), sponsored by Vericel. Primary endpoints: Progression of osteonecrosis at 6 months and Hip survival at 6 months. Started May 2006; status: active.
02
Drugs
Tissue Repair Cells
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on 2006-001286-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001286-42.